(Q45757824)

English

Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects

scientific article published on January 1, 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

Cross-Clade Immune Responses after Immunization with a Whole-Killed gp120-Depleted Human Immunodeficiency Virus Type-1 Immunogen in Incomplete Freund's Adjuvant (HIV-1 Immunogen, Remune™) in Human Immunodeficiency Virus Type-1 Seropositive Subjects (English)

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

0 references

author name string

R. B. Moss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

W. Giermakowska

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

P. Lanza

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

J. L. Turner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

M. R. Wallace

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

F. C. Jensen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

G. Theofan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

S. P. Richieri

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

D. J. Carlo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9473153

7 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9473153

7 December 2024

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9473153

7 December 2024

full work available at URL

https://www.liebertpub.com/doi/pdf/10.1089/vim.1997.10.221

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Viral Immunology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

221-228

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant

3

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

4

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

5

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa

6

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins

7

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Investigations of the use of beta-propiolactone in virus inactivation

8

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

HIV-1-Specific Functional Immune Measurements as Markers of Disease Progression

9

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection

10

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

11

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Effect of immunization with inactivated gp120-depleted human immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral DNA, and percentage of CD4 cells

12

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).

13

1 reference

10.1089/VIM.1997.10.221

https://api.crossref.org/works/10.1089/VIM.1997.10.221

7 December 2024

Identifiers

10.1089/VIM.1997.10.221

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/9473153

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45757824&oldid=2284616317"